Clinical Trial Update: Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of OnabotulinumtoxinA for the Depressor Anguli Oris in aging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: Amir Moradi MD, MBA | Conditions: Aging | Phase 4 | Status: NOT_YET_RECRUITING